Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Biliary Tract Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    April 2023
  1. LEWINSKA M, Karhus ML, Ellegaard AG, Romero-Gomez M, et al
    Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
    Gut. 2023 Apr 18:gutjnl-2022-329213. doi: 10.1136/gutjnl-2022-329213.
    PubMed     Abstract available


    February 2023
  2. HALLENSLEBEN ND, Stassen PMC, Schepers NJ, Besselink MG, et al
    Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study.
    Gut. 2023 Feb 27:gutjnl-2022-328258. doi: 10.1136/gutjnl-2022-328258.
    PubMed     Abstract available


  3. BEYER G, Kasprowicz F, Hannemann A, Aghdassi A, et al
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort study.
    Gut. 2023 Feb 24:gutjnl-2021-326106. doi: 10.1136/gutjnl-2021-326106.
    PubMed     Abstract available


  4. MEMON SF, Jagtap N, Reddy DN
    Reply to Sachan and Mandavdhare.
    Gut. 2023;72:408-409.
    PubMed    


    July 2022
  5. MONIN MB, Baier L, Berger M, Gorny JG, et al
    SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination.
    Gut. 2022 Jul 26. pii: gutjnl-2022-328169. doi: 10.1136/gutjnl-2022-328169.
    PubMed    


    June 2022
  6. MORITA S, Duda DG
    Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?
    Gut. 2022 Jun 30. pii: gutjnl-2022-327782. doi: 10.1136/gutjnl-2022-327782.
    PubMed    


  7. FICKERT P
    Bacteria as key players in primary sclerosing cholangitis?
    Gut. 2022 Jun 28. pii: gutjnl-2022-327876. doi: 10.1136/gutjnl-2022-327876.
    PubMed    


  8. AWONIYI M, Wang J, Ngo B, Meadows V, et al
    Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC.
    Gut. 2022 Jun 15. pii: gutjnl-2021-326500. doi: 10.1136/gutjnl-2021-326500.
    PubMed     Abstract available


  9. MAKKI K, Brolin H, Petersen N, Henricsson M, et al
    6alpha-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice.
    Gut. 2022 Jun 13. pii: gutjnl-2021-326541. doi: 10.1136/gutjnl-2021-326541.
    PubMed     Abstract available


  10. ESSEILI MA
    Great escape: how infectious SARS-CoV-2 avoids inactivation by gastric acidity and intestinal bile.
    Gut. 2022 Jun 7. pii: gutjnl-2021-326624. doi: 10.1136/gutjnl-2021-326624.
    PubMed    


    May 2022
  11. MARTIN-SERRANO MA, Kepecs B, Torres-Martin M, Bramel ER, et al
    Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications.
    Gut. 2022 May 18. pii: gutjnl-2021-326514. doi: 10.1136/gutjnl-2021-326514.
    PubMed     Abstract available


  12. CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
    Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
    Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
    PubMed     Abstract available


  13. MACIAS RIR, Cardinale V, Kendall TJ, Avila MA, et al
    Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
    Gut. 2022 May 17. pii: gutjnl-2022-327099. doi: 10.1136/gutjnl-2022-327099.
    PubMed     Abstract available


    April 2022
  14. ZHAO Y, Ren X, Lu J, He M, et al
    Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids.
    Gut. 2022 Apr 22. pii: gutjnl-2021-326617. doi: 10.1136/gutjnl-2021-326617.
    PubMed    


  15. VOSKENS C, Stoica D, Rosenberg M, Vitali F, et al
    Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis.
    Gut. 2022 Apr 15. pii: gutjnl-2022-327075. doi: 10.1136/gutjnl-2022-327075.
    PubMed     Abstract available


    March 2022
  16. SACHAN A, Mandavdhare HS
    EUS versus MRCP in patients with intermediate risk of choledocholithiasis: clinical and statistical viewpoint.
    Gut. 2022 Mar 8. pii: gutjnl-2022-327239. doi: 10.1136/gutjnl-2022-327239.
    PubMed    


  17. PAGANO E, Elias JE, Schneditz G, Saveljeva S, et al
    Activation of the GPR35 pathway drives angiogenesis in the tumour microenvironment.
    Gut. 2022;71:509-520.
    PubMed     Abstract available


    February 2022
  18. JAGTAP N, Kumar JK, Chavan R, Basha J, et al
    EUS versus MRCP to perform ERCP in patients with intermediate likelihood of choledocholithiasis: a randomised controlled trial.
    Gut. 2022 Feb 10. pii: gutjnl-2021-325080. doi: 10.1136/gutjnl-2021-325080.
    PubMed     Abstract available


    January 2022
  19. VARGHESE C, Nayar M, Pandanaboyana S
    SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK.
    Gut. 2022 Jan 17. pii: gutjnl-2021-326845. doi: 10.1136/gutjnl-2021-326845.
    PubMed    


    December 2021
  20. AMPUERO J, Lucena A, Hernandez-Guerra M, Moreno-Moraleda I, et al
    Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
    Gut. 2021 Dec 7. pii: gutjnl-2021-325700. doi: 10.1136/gutjnl-2021-325700.
    PubMed    


    October 2021
  21. TRAUNER M, Fuchs CD
    Novel therapeutic targets for cholestatic and fatty liver disease.
    Gut. 2021 Oct 6. pii: gutjnl-2021-324305. doi: 10.1136/gutjnl-2021-324305.
    PubMed     Abstract available


  22. TRIVEDI PJ, Hirschfield GM
    Recent advances in clinical practice: epidemiology of autoimmune liver diseases.
    Gut. 2021;70:1989-2003.
    PubMed     Abstract available


    August 2021
  23. RUFFOLO LI, Jackson KM, Kuhlers PC, Dale BS, et al
    GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
    Gut. 2021 Aug 19. pii: gutjnl-2021-324109. doi: 10.1136/gutjnl-2021-324109.
    PubMed     Abstract available


    July 2021
  24. ARECHEDERRA M, Rullan M, Amat I, Oyon D, et al
    Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.
    Gut. 2021 Jul 20. pii: gutjnl-2021-325178. doi: 10.1136/gutjnl-2021-325178.
    PubMed     Abstract available


  25. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available


  26. YAMAO K, Kitano M, Chiba Y, Ogura T, et al
    Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.
    Gut. 2021;70:1244-1252.
    PubMed     Abstract available


    May 2021
  27. LIU Q, Li B, Li Y, Wei Y, et al
    Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
    Gut. 2021 May 25. pii: gutjnl-2020-323565. doi: 10.1136/gutjnl-2020-323565.
    PubMed     Abstract available


    February 2021
  28. FROMME M, Schneider CV, Pereira V, Hamesch K, et al
    Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency.
    Gut. 2021 Feb 25. pii: gutjnl-2020-323729. doi: 10.1136/gutjnl-2020-323729.
    PubMed     Abstract available


  29. AHMED W, Joshi D, Harrison P, Reffitt D, et al
    Intraductal bile duct stents should be prioritised for removal during the pandemic.
    Gut. 2021 Feb 1. pii: gutjnl-2021-324105. doi: 10.1136/gutjnl-2021-324105.
    PubMed    


    January 2021
  30. GOEPPERT B, Stichel D, Toth R, Fritzsche S, et al
    Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
    Gut. 2021 Jan 19. pii: gutjnl-2020-322983. doi: 10.1136/gutjnl-2020-322983.
    PubMed     Abstract available


  31. AOKI S, Inoue K, Klein S, Halvorsen S, et al
    Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
    Gut. 2021 Jan 11. pii: gutjnl-2020-322493. doi: 10.1136/gutjnl-2020-322493.
    PubMed     Abstract available


    November 2020
  32. WAUTERS L, Ceulemans M, Lambaerts M, Accarie A, et al
    Association between duodenal bile salts and gastric emptying in patients with functional dyspepsia.
    Gut. 2020 Nov 25. pii: gutjnl-2020-323598. doi: 10.1136/gutjnl-2020-323598.
    PubMed    


  33. TAKEUCHI M, Vidigal PT, Guerra MT, Hundt MA, et al
    Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322540. doi: 10.1136/gutjnl-2020-322540.
    PubMed     Abstract available


  34. CALDERARO J, Kather JN
    Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers.
    Gut. 2020 Nov 19. pii: gutjnl-2020-322880. doi: 10.1136/gutjnl-2020-322880.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: